Scott Bizily 4 D Molecular Therapeutics, Inc. (FDMT) insider trading activity

FDMT Quotes by TradingView

Scott Bizily is Chief Legal Officer of 4D Molecular Therapeutics, Inc.. Currently has a direct ownership of 1,737 shares of FDMT, which is worth approximately $36,459. The most recent transaction as insider was on Jun 17, 2024, when has been sold 1,750 shares (Common Stock) at a price of $23.71 per share, resulting in proceeds of $41,492. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.74K
0% 3M change
0% 12M change
Total Value Held $36,459

Scott Bizily Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 17 2024
SELL
Open market or private sale
$41,492 $23.71 p/Share
1,750 Reduced 50.19%
1,737 Common Stock
Jun 17 2024
BUY
Exercise of conversion of derivative security
$12,722 $7.27 p/Share
1,750 Added 33.42%
3,487 Common Stock
May 16 2024
SELL
Open market or private sale
$44,712 $25.55 p/Share
1,750 Reduced 50.19%
1,737 Common Stock
May 16 2024
BUY
Exercise of conversion of derivative security
$12,722 $7.27 p/Share
1,750 Added 33.42%
3,487 Common Stock
Apr 16 2024
SELL
Open market or private sale
$45,045 $25.74 p/Share
1,750 Reduced 50.19%
1,737 Common Stock
Apr 16 2024
BUY
Exercise of conversion of derivative security
$12,722 $7.27 p/Share
1,750 Added 33.42%
3,487 Common Stock
Apr 01 2024
SELL
Open market or private sale
$259,102 $31.78 p/Share
8,153 Reduced 82.44%
1,737 Common Stock
Apr 01 2024
BUY
Exercise of conversion of derivative security
$103,053 $12.64 p/Share
8,153 Added 45.19%
9,890 Common Stock
Mar 27 2024
SELL
Open market or private sale
$204,388 $35.04 p/Share
5,833 Reduced 77.05%
1,737 Common Stock
Mar 27 2024
BUY
Exercise of conversion of derivative security
$151,541 $25.98 p/Share
5,833 Added 43.52%
7,570 Common Stock
Mar 18 2024
SELL
Open market or private sale
$54,722 $31.27 p/Share
1,750 Reduced 50.19%
1,737 Common Stock
Mar 18 2024
BUY
Exercise of conversion of derivative security
$12,722 $7.27 p/Share
1,750 Added 33.42%
3,487 Common Stock
Feb 27 2024
SELL
Open market or private sale
$57,270 $30.0 p/Share
1,909 Reduced 52.36%
1,737 Common Stock
Feb 27 2024
BUY
Exercise of conversion of derivative security
$38,638 $20.24 p/Share
1,909 Added 34.37%
3,646 Common Stock
Feb 16 2024
SELL
Open market or private sale
$48,422 $27.67 p/Share
1,750 Reduced 50.19%
1,737 Common Stock
Feb 16 2024
BUY
Exercise of conversion of derivative security
$12,722 $7.27 p/Share
1,750 Added 33.42%
3,487 Common Stock
Feb 08 2024
SELL
Open market or private sale
$171,710 $27.5 p/Share
6,244 Reduced 78.24%
1,737 Common Stock
Feb 08 2024
BUY
Exercise of conversion of derivative security
$63,064 $10.1 p/Share
6,244 Added 62.58%
3,733 Common Stock
Jun 08 2023
SELL
Open market or private sale
$78,187 $20.85 p/Share
3,750 Reduced 68.34%
1,737 Common Stock
Jun 08 2023
BUY
Exercise of conversion of derivative security
$30,149 $8.04 p/Share
3,750 Added 40.6%
5,487 Common Stock
Jun 01 2023
SELL
Open market or private sale
$41,142 $18.31 p/Share
2,247 Reduced 56.4%
1,737 Common Stock
Jun 01 2023
BUY
Exercise of conversion of derivative security
$12,168 $6.49 p/Share
1,875 Added 32.0%
3,984 Common Stock
Apr 21 2023
SELL
Open market or private sale
$75,000 $20.0 p/Share
3,750 Reduced 64.0%
2,109 Common Stock
Apr 21 2023
BUY
Exercise of conversion of derivative security
$30,149 $8.04 p/Share
3,750 Added 39.03%
5,859 Common Stock
Mar 01 2023
SELL
Open market or private sale
$43,386 $19.3 p/Share
2,248 Reduced 51.6%
2,109 Common Stock
SB

Scott Bizily

Chief Legal Officer
Emeryville, CA

Track Institutional and Insider Activities on FDMT

Follow 4D Molecular Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FDMT shares.

Notify only if

Insider Trading

Get notified when an 4 D Molecular Therapeutics, Inc. insider buys or sells FDMT shares.

Notify only if

News

Receive news related to 4D Molecular Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FDMT